{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:58:54Z","timestamp":1793444334719,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Anesthesia, University of Toronto","award":["the Merit Award"],"award-info":[{"award-number":["the Merit Award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12630-018-1108-0","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:03:23Z","timestamp":1522796603000},"page":"709-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Updated guide for the management of malignant hyperthermia","Mise \u00e0 jour sur la gestion de l\u2019hyperthermie maligne"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0670-1516","authenticated-orcid":false,"given":"Sheila","family":"Riazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kraeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"key":"1108_CR1","doi-asserted-by":"crossref","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis 2015; 10: 93 ( free access ).","DOI":"10.1186\/s13023-015-0310-1"},{"key":"1108_CR2","doi-asserted-by":"crossref","unstructured":"Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology 2018; 128: 168-80.","DOI":"10.1097\/ALN.0000000000001878"},{"key":"1108_CR3","doi-asserted-by":"crossref","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 2014; 118: 381-7.","DOI":"10.1213\/ANE.0b013e3182937d8b"},{"key":"1108_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg 2010; 110: 498-507.","journal-title":"Anesth Analg"},{"key":"1108_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jclinane.2017.03.016","volume":"39","author":"Z Lu","year":"2017","unstructured":"Lu Z, Rosenberg H, Li G. Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin. J Clin Anesth 2017; 39: 10-4.","journal-title":"J Clin Anesth"},{"key":"1108_CR6","first-page":"700","volume":"64","author":"H Ording","year":"1985","unstructured":"Ording H. Incidence of malignant hyperthermia in Denmark. Anesth Analg 1985; 64: 700-4.","journal-title":"Anesth Analg"},{"key":"1108_CR7","doi-asserted-by":"crossref","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis 2007; 2: 21 (free access).","DOI":"10.1186\/1750-1172-2-21"},{"key":"1108_CR8","doi-asserted-by":"crossref","unstructured":"Monnier N, Krivosic-Horber R, Payen JF, et al. Presence of two different genetic traits in malignant hyperthermia families: Implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 2002; 97: 1067-74 (free access).","DOI":"10.1097\/00000542-200211000-00007"},{"key":"1108_CR9","doi-asserted-by":"crossref","unstructured":"Gonsalves SG, Ng D, Johnston JJ, et al. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology 2013; 119: 1043-53 (free access).","DOI":"10.1097\/ALN.0b013e3182a8a8e7"},{"key":"1108_CR10","doi-asserted-by":"crossref","unstructured":"Carpenter D, Robinson RL, Quinnell RJ, et al. Genetic variation in RYR1 and malignant hyperthermia phenotypes. Br J Anaesth 2009; 103: 538-48 (free access).","DOI":"10.1093\/bja\/aep204"},{"key":"1108_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00439-002-0864-6","volume":"112","author":"R Robinson","year":"2003","unstructured":"Robinson R, Hopkins P, Carsana A, et al. Several interacting genes influence the malignant hyperthermia phenotype. Hum Genet 2003; 112: 217-8.","journal-title":"Hum Genet"},{"key":"1108_CR12","doi-asserted-by":"crossref","unstructured":"Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth 2011; 107: 48-56 (free access).","DOI":"10.1093\/bja\/aer132"},{"key":"1108_CR13","doi-asserted-by":"crossref","unstructured":"Heytens L, Forget P, Scholtes JL, Veyckemans F. The changing face of malignant hyperthermia: Less fulminant, more insidious. Anaesth Intensive Care 2015; 43: 506-11 (free access).","DOI":"10.1177\/0310057X1504300415"},{"key":"1108_CR14","doi-asserted-by":"crossref","unstructured":"Rosero EB, Adesanya AO, Timaran CH, Joshi GP. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology 2009; 110: 89-94 (free access).","DOI":"10.1097\/ALN.0b013e318190bb08"},{"key":"1108_CR15","doi-asserted-by":"crossref","unstructured":"Schneiderbanger D, Johannsen S, Roewer N, Schuster F. Management of malignant hyperthermia: diagnosis and treatment. Ther Clin Risk Manag 2014; 10: 355-62 (free access).","DOI":"10.2147\/TCRM.S47632"},{"key":"1108_CR16","doi-asserted-by":"crossref","unstructured":"Glahn KP, Ellis FR, Halsall PJ, et al . Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth 2010; 105: 417-20 ( free access ).","DOI":"10.1093\/bja\/aeq243"},{"key":"1108_CR17","doi-asserted-by":"crossref","unstructured":"Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771-9 (free access).","DOI":"10.1097\/00000542-199404000-00008"},{"key":"1108_CR18","doi-asserted-by":"crossref","unstructured":"Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the Malignant Hyperthermia Association of the United States. Anesth Analg 2014; 119: 1359-66 (free access).","DOI":"10.1213\/ANE.0000000000000421"},{"key":"1108_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","volume":"69","author":"MG Larach","year":"1989","unstructured":"Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-5.","journal-title":"Anesth Analg"},{"key":"1108_CR20","doi-asserted-by":"crossref","unstructured":"Hopkins PM, Ruffert H, Snoeck MM, et al. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 2015; 115: 531-9 (free access).","DOI":"10.1093\/bja\/aev225"},{"key":"1108_CR21","doi-asserted-by":"crossref","unstructured":"Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology 1998; 88: 579-88 (free access).","DOI":"10.1097\/00000542-199803000-00006"},{"key":"1108_CR22","doi-asserted-by":"crossref","unstructured":"Horstick EJ, Linsley JW, Dowling JJ, et al. Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. Nat Commun 2013; 4: 1952 (free access).","DOI":"10.1038\/ncomms2952"},{"key":"1108_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1213\/ANE.0000000000000063","volume":"118","author":"KM Stowell","year":"2014","unstructured":"Stowell KM. DNA testing for malignant hyperthermia: the reality and the dream. Anesth Analg 2014; 118: 397-406.","journal-title":"Anesth Analg"},{"key":"1108_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12630-017-0865-5","volume":"64","author":"N Kraeva","year":"2017","unstructured":"Kraeva N, Sapa A, Dowling JJ, Riazi S. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review. Can J Anesth 2017; 64: 736-43.","journal-title":"Can J Anesth"},{"key":"1108_CR25","doi-asserted-by":"crossref","unstructured":"Riazi S, Kraeva N, Muldoon SM, et al. Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS scientific conference. Can J Anesth 2014; 61: 1040-9 (free access).","DOI":"10.1007\/s12630-014-0227-5"},{"key":"1108_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","volume":"128","author":"RS Litman","year":"2018","unstructured":"Litman RS, Griggs SM, Dowling JJ, Riazi S. Malignant hyperthermia susceptibility and related diseases. Anesthesiology 2018; 128: 159-67.","journal-title":"Anesthesiology"},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nmd.2016.02.007","volume":"26","author":"AK Bamaga","year":"2016","unstructured":"Bamaga AK, Riazi S, Amburgey K, et al. Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: a 25-year retrospective study. Neuromuscul Disord 2016; 26: 201-6.","journal-title":"Neuromuscul Disord"},{"key":"1108_CR28","doi-asserted-by":"crossref","unstructured":"O\u2019Flynn RP, Shutack JG, Rosenberg H, Fletcher JE. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. Anesthesiology 1994; 80: 1228-33 (free access).","DOI":"10.1097\/00000542-199406000-00009"},{"key":"1108_CR29","doi-asserted-by":"crossref","unstructured":"Russell T, Riazi S, Kraeva N, Steel AC, Hawryluck LA. Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia 2012; 67: 1021-4 (free access).","DOI":"10.1111\/j.1365-2044.2012.07226.x"},{"key":"1108_CR30","doi-asserted-by":"crossref","unstructured":"Burkman JM, Posner KL, Domino KB. Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions. Anesthesiology 2007; 106: 901-6 (free access).","DOI":"10.1097\/01.anes.0000265148.86566.68"},{"key":"1108_CR31","doi-asserted-by":"crossref","unstructured":"Dobson G, Chong M, Chow L, et al. Guidelines to the practice of anesthesia - revised edition 2017. Can J Anesth 2017; 64: 65-91 (free access).","DOI":"10.1007\/s12630-016-0749-0"},{"key":"1108_CR32","doi-asserted-by":"crossref","unstructured":"Barnes C, Stowell KM, Bulger T, Langton E, Pollock N. Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update. Anaesth Intensive Care 2015; 43: 98-104 (free access).","DOI":"10.1177\/0310057X1504300115"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-018-1108-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-018-1108-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-018-1108-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T19:54:37Z","timestamp":1604087677000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-018-1108-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1007\/s12630-018-1108-0","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}